Determination of an effective rate constant and activation energy allowed the application of steady-state theory to predict concentrations of compound A from sevoflurane concentrations, fresh gas flow rate, absorbent temperature and amount of absorbent. Studies by eight research groups were compared. Lower concentrations of compound A than predicted were observed at low flow rates, suggesting that its degradation by the absorbent is important in limiting the maximum observed concentrations in closed and low-flow breathing systems. Trial-to-trial and batch-to-batch variations in compound A concentrations were observed in model system tests of commercial and pilot-plant absorbents. Chemical modification of the absorbent with glycerol lowered concentrations of compound A, possibly by formation of a nucleophilic addition product. An ideal chemical scavenger would remain stable and non-volatile in the absorbent before irreversibly reacting with compound A to form a stable non-volatile product. (Br. J. Anaesth. 1996;77:537-543) Key words Anaesthetics volatile, sevoflurane. Carbon dioxide, absorption. Equipment, breathing systems.
Sevoflurane may degrade to form compound A and other degradation products ( fig. 1 ). Methanol may further add to compounds C, D and E to form progressively larger molecular weight degradation products (structures not shown). In most studies reported in the literature, the concentration of compound A increases to a near steady-state concentration [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . In this study, determination of an effective rate constant and activation energy allowed the application of a steady-state theory to predict steady-state compound A concentrations from sevoflurane concentrations, fresh gas flow rate, absorbent temperature and amount of absorbent. Development of the theoretical model allowed comparison of results from eight research groups during July 1995. Confirmation of the theory was attempted using a model breathing system with standard and modified absorbent canisters.
The composition of the absorbent has also been viewed as a factor in the generation of compound A 2 3 9 [13] [14] [15] [16] [17] . Pilot-plant batches of absorbent with different concentrations of sodium hydroxide and potassium hydroxide were tested in a model breathing system under conditions designed to produce high concentrations of compound A. The possible role of moisture is discussed.
Previous detection of compound B in low-flow breathing systems 3 8 10 13 14 suggested that addition of an alcohol to compound A readily occurred. Laboratory batches of absorbent were modified with two non-volatile alcohols, glycerol and polyvinyl alcohol, and tested. 
Materials and methods
Simulated clinical conditions were produced using a Drager Narcomed anaesthesia machine with ventilator, Drager vaporizer, Marquest humidifier, breathing system and humidification chamber with a Gibeck heavy wall test lung attached to the y-site. Standard conditions of 1.5% sevoflurane, oxygen 250 ml min
91
, nitrous oxide 250 ml min 91 and carbon dioxide 340 ml min 91 into the y-site, tidal volume 500 ml, 16 bpm and carbon dioxide absorbent 1 kg were monitored using a Datex Capnomac Ultima gas analyser, unless otherwise noted. The carbon dioxide flow rate was large to produce high temperatures in the absorbent and production of compound A.
A range of temperatures for the Arrhenius plot ( fig.  2 ) was generated using standard conditions, except for carbon dioxide 0-400 ml min
. Flow rate dependance was studied over the range 0.5-4 litre min
, otherwise using standard conditions. The rates were tested randomly and each held constant until a near steady-state compound A concentration was reached. Sevoflurane concentrations of 1.5% and 4.0% were used to test concentration dependence. One batch of Sodasorb was separated into 4, 6, 8 and 12 mesh fractions. The amounts of 4 and 12 mesh material were insufficient for testing.
Absorption of compound A to materials in the breathing system was tested using 0.7-3.4 ppm of compound A in 1-5% sevoflurane without absorbent in the canisters. Temperatures were measured with custom-made type K thermocouples using a National Instruments A/D converter with Lab View software. Forced air cooling was conducted using modified absorbent canisters constructed using 18 equally spaced 0.5-mm thick metal cylinders which were inserted in place of the standard double canister ( fig. 2 ). Convective cooling was conducted using canisters with 19 cylinders (0.5-1.2 mm) without the outer baffled shroud shown in figure 2. Laboratory batches of absorbent were prepared with a water content of approximately 35%, passed through a grinder with 3-4 mm holes in the extrusion plate, and dried further to values reported before use.
Concentrations of compound A were measured using a gas chromatography method described previously 18 . Standard addition/recovery experiments performed by two analysts in the range 4-32 ppm were found to give an overall recovery of 102% (n:12, range 88-117%, sd 9%). The variation in the standard addition/recovery results included any variation in the preparation of the samples, and the normal variation in the assay. Generally, concentrations of compound A were measured in the model breathing system every 15-30 min for at least 150 min. For convenience, only the maximum concentration found during each experiment is reported.
THEORY
A steady-state approximation was formulated to predict the steady-state concentration of compound A based on the factors of sevoflurane concentration, fresh gas flow rate, temperature and amount of absorbent. At steady-state, the amount of compound A formed in the breathing system is assumed to be equal to the amount of compound A carried out of the system by the fresh gas flow, as shown in equation volume of water in the absorbent. The effective activation energy can be calculated from:
where k 1 and k2:rate constants at temperatures T1 and T2 and R:gas constant. Therefore, by plotting log k against 1/T (an Arrhenius plot) for a range of temperatures, the slope of the line provides the net result of all the unknowns in equation (2) . When the activation energy is known, and the rate constant at one temperature T1 is also known, the rate constant at any other temperature T2 can be determined by rearranging equation (2) and solving for k2.
Results
The effective rate constant for degradation to compound A was determined at 24 ЊC with 1 kg of Sodasorb and 18% water, using standard conditions without introduction of carbon dioxide. The near steady-state compound A concentration in the system was then 6 ppm, produced from a reaction volume of 180 ml (18% of 1 kg), a sevoflurane fraction of 0.015 and a fresh gas flow rate of 500 ml min
91
. The calculated rate constant from equation (1) . The temperature dependence of the near steadystate compound A concentration in the breathing system for maximal temperatures of 24-60 ЊC is presented in the form of an Arrhenius plot in figure 3 . The effective activation energy for the formation of compound A, Ea, calculated from the slope of the line in figure 3 using equation (2), is 39 kJ mol
. An effective activation energy of 39 kJ mol 91 and an effective rate constant of 1. 9 10 95 s 91 at 24 ЊC were used to calculate (from a rearranged equation (2)) the effective rate constants for the maximum temperatures reported in different studies. Then, equation (1) was used to calculate the predicted near steady-state compound A concentration from the sevoflurane fraction, fresh gas flow rate and amount of absorbent used in the study (assuming a water figure 4 . Increasing the sevoflurane concentration from 1.5% to 4.0% after 2 h did not change the characteristic shape of the temperature profile (data not shown). Initially, carbon dioxide was absorbed in a narrow carbon dioxide reaction zone at the top of the absorbent. As observed by the change in colour of the pH indicator, this zone moved along the absorbent with time. As shown in figure 4 , the maximal temperatures reached at the centre of the canister remained nearly constant with time, indicating efficient heat transfer from the carbon dioxide reaction zone. The wall portions of the absorbent reached temperature maxima at progressively later times, but the combined mean temperature of the wall sites remained approximately constant.
Results from studies performed with commercially available absorbents are shown in table 2. Results from the fresh gas flow rate study are shown in figure 5 . The measured absorbent temperature was approximately constant (46 < 3 ЊC) at each flow rate. Increasing the sevoflurane concentration from 1.5% to 4.0% increased mean maximal steadystate concentrations of compound A from 22 to 69 ppm (n:3). The 6 and 8 mesh fractions gave maximum compound A concentrations of 34 ppm and 33 ppm (table 2). In the absorption study, recovery of compound A from the breathing system in the absence of absorbent was 102-114%.
Results from pilot-plant batches of absorbent prepared with different concentrations of sodium and potassium hydroxide are shown in table 3. During initial studies, the lowest concentrations of compound A were observed with about 5% sodium hydroxide, which led to the preparation of a production batch which gave a higher concentration of compound A than any of the pilot-plant batches. The ranges of values observed for both sodium hydroxide batches (9-34 ppm) and potassium hydroxide batches (19- 
Discussion
The temperature profiles within the canister were complex ( fig. 4 ), but attainment of near steady-state concentrations of compound A over long periods of time showed that the effective temperature was relatively constant. Thus an effective activation energy and effective reaction rates could be calculated. Arrhenius plots of near steady-state concentrations of compound A reported in previous studies (plots not shown) gave effective activation energies of 29 kJ mol 91 
10
, 76 kJ mol 91 
11
, 55 kJ mol 91 19 and 28 kJ mol human clinical studies the predicted values are comparable with the measured variables (within ;6 to 911 ppm of predicted values), except for the study of 16 patients at site three using a fresh gas flow of 0.5 litre min
91
, where a much higher concentration was predicted. However, in clinical practice the entire fresh gas flow is not available to carry compound A out of the breathing system as approximately 80-250 ml min 91 of oxygen are converted to carbon dioxide by the patient 3 . If this were corrected for by using a smaller fresh gas flow in equation (1), the predicted concentration would be even higher. In model systems (with no oxygen absorption), the predictions were also much higher than the measured values at fresh gas flow rates of less than 0.5 litre min
. The steady-state approximation (equation (1)) predicts that as the fresh gas flow rate approaches 0, concentrations of compound A should approach infinity, in contrast with the finite experimental results for closed systems. The most likely explanation for this discrepancy is that a substantial fraction of compound A is degraded during recirculation through the carbon dioxide scrubber. Degradation of compound A in the presence of soda lime has been described 13 ; however, insufficient detail exists to calculate the magnitude of removal of compound A from the breathing system by this mechanism. Large non-volatile products could be formed from compound A by repeated additions of methanol and elimination of hydrogen fluoride (an extension of the reaction scheme in fig. 1 ). Absorption of compound A to the breathing system in the absence of a carbon dioxide absorbent did not appear to be a factor. Further clarification of the degradation of compound A was beyond the scope of our studies.
As described here and elsewhere, results for the individual factors of sevoflurane concentration 12 13 , and temperature 10 11 13 19 were in general agreement with the theory. In previous studies, fresh gas flow rate dependence was noted; however, in these studies the temperature varied over a range greater than 15 ЊC so the true flow rate dependence was not determined 1 11 . However, table 1 sheds no light on the effect of the amount of absorbent on the concentration of compound A because most of the experiments with smaller amounts used fresh gas flows of less than 0.5 litre min
. The limited data from our own experiments (table 2) tend to contradict the theory showing lower concentrations with larger amounts.
The effective reaction volume may be affected by the moisture content of the absorbent. The surface area of 4-8 mesh absorbent has been estimated as 600 cm 2 cc
, but only 16% of the area is active in absorbing carbon dioxide because water fills much of the internal pores 20 . The moisture content may change during absorption of carbon dioxide, as the heat of reaction of 1 mol of carbon dioxide (which produces, 1 mol, i.e. 18 g of water) is sufficient to vaporize 25 g of water 21 . Measurements of actual vaporization and calorimetry of the system are complex as the heat of reaction is carried away by the recirculating gas, increases the temperature of the soda lime and vaporizes water. The humidity of the recirculating gas should also affect the amount of water vaporized and the increase in temperature in the absorbent. Thus the initial moisture content of the absorbent may significantly affect the sevoflurane degradation reaction volume, and many factors may affect the moisture content and surface area of the absorbent during use. Drying Sodasorb from 16% to 11% moisture had little effect on the concentrations of compound A, but drying to 2-6% moisture produced greater concentrations, contrary to the effect of V in equation (1) and different ratios of degradation products 18 , suggesting that the chemical mechanism of degradation is dramatically different on a dry surface.
There are contradictory reports on the role of sodium hydroxide, potassium hydroxide and barium hydroxide on the degradation of sevoflurane to compound A 2 3 9 13-17 . Significant variability was observed with commercial absorbents (table 2) . Pilot-plant batches of absorbent containing 5% sodium hydroxide from vendor 1 (table 3) gave concentrations of compound A which were less than half the concentrations found for Sodasorb. A 5% sodium hydroxide absorbent batch made to production scale by the vendor and pilot-plant batches prepared by a second vendor gave high concentrations of compound A. Pilot-plant batches prepared without either sodium or potassium hydroxide still absorbed carbon dioxide, but with lower efficiency, and produced significant compound A concentrations.
The cause of the variation in compound A concentrations observed with commercial absorbents is unclear (table 2). The variability in size distribution and composition of an absorbent during normal production is low. Thus variability in drying conditions and other manufacturing steps, which may lead to different amounts of reactive surface area, is a more likely explanation. More accurate measurement of the variability of commercial absorbents and clarification of the role of production variables was not pursued A chemical approach to scavenge compound A from the breathing system was investigated. An ideal chemical scavenger would be stable and non-volatile in the chemically basic conditions of soda lime or Baralyme, would react with compound A, and form a relatively stable non-volatile product with compound A. The reaction scheme in figure 1 shows that methanol adds across the double bond of compound A to form compound B. Although concentrations of methanol were not measured ( fig. 1 ), low concentrations would be expected as little sevoflurane degrades and the formation of hydrogen from basic solutions of formaldehyde competes with the Cannizarro reaction 22 . Low concentrations of compound B have been detected in breathing systems 3 8 10 13 14 ; thus, the nucleophilic addition of methanol readily occurred. Glycerol and polyvinyl alcohol were tested as additives in various calcium hydroxide-based absorbents. As the results in table 4 show, for each type of absorbent tested the concentration of compound A was lower when glycerol was present. These results support the principle of chemical scavenging. The concentrations of compound A with sodium hydroxide-type absorbents were lower than with the potassium hydroxidetype absorbents. Absorbent prepared with polyvinyl alcohol additive gave high concentrations of compound A, possibly because of increased absorption of sevoflurane into the non-polar portion of the polyvinyl alcohol polymer, which effectively increased the contact area with the highly basic absorbent. Results for the Molecular Products Sofnoline GB (table 2) , which is not used routinely in breathing systems for general anaesthesia, showed that potassium permanganate used as the indicator may also affect the concentration. Identification of a more reactive additive was not pursued as the maximum concentration of compound A formed in the breathing system appears to be limited by the main factors in the steady-state model, and at low fresh gas flow rates the maximum concentration appears to be limited further by degradation of compound A.
